The role of ATM in response to metformin treatment and activation of AMPK.
作者信息
Yee Sook Wah, Chen Ligong, Giacomini Kathleen M
出版信息
Nat Genet. 2012 Mar 28;44(4):359-60. doi: 10.1038/ng.2236.
Abstract
摘要
相似文献
1
The role of ATM in response to metformin treatment and activation of AMPK.
Nat Genet. 2012 Mar 28;44(4):359-60. doi: 10.1038/ng.2236.
2
The role of ATM in response to metformin treatment and activation of AMPK.
Nat Genet. 2012 Mar 28;44(4):360-1. doi: 10.1038/ng.2235.
3
The role of ATM in response to metformin treatment and activation of AMPK.
Nat Genet. 2012 Mar 28;44(4):361-2. doi: 10.1038/ng.2234.
4
Metformin activates an ataxia telangiectasia mutated (ATM)/Chk2-regulated DNA damage-like response.
Cell Cycle. 2011 May 1;10(9):1499-501. doi: 10.4161/cc.10.9.15423.
5
Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes.
Nat Genet. 2011 Feb;43(2):117-20. doi: 10.1038/ng.735. Epub 2010 Dec 26.
6
Genomics: Drugs, diabetes and cancer.
Nature. 2011 Feb 17;470(7334):338-9. doi: 10.1038/470338a.
7
Highlights from the latest pharmacogenomic genome-wide association studies.
Pharmacogenomics. 2013 Mar;14(4):357-60. doi: 10.2217/pgs.13.17.
8
ATM targets hnRNPK to control p53.
Cell Cycle. 2013 Apr 15;12(8):1162-3. doi: 10.4161/cc.24485. Epub 2013 Apr 2.
9
The C allele of ATM rs11212617 does not associate with metformin response in the Diabetes Prevention Program.
Diabetes Care. 2012 Sep;35(9):1864-7. doi: 10.2337/dc11-2301. Epub 2012 Jun 29.
10
Fine-tuning the p53 response to DNA damage: a new piece in the puzzle.
Cell Cycle. 2013 May 1;12(9):1337-8. doi: 10.4161/cc.24669. Epub 2013 Apr 15.
引用本文的文献
1
Overview of Metformin and Neurodegeneration: A Comprehensive Review.
Pharmaceuticals (Basel). 2025 Mar 28;18(4):486. doi: 10.3390/ph18040486.
2
Hyperglycemia-induced Sirt3 downregulation increases microglial aerobic glycolysis and inflammation in diabetic neuropathic pain pathogenesis.
CNS Neurosci Ther. 2024 Aug;30(8):e14913. doi: 10.1111/cns.14913.
3
Repurposing Metformin for the Treatment of Atrial Fibrillation: Current Insights.
Vasc Health Risk Manag. 2024 Jun 21;20:255-288. doi: 10.2147/VHRM.S391808. eCollection 2024.
4
Mitochondrial Signaling Pathways Associated with DNA Damage Responses.
Int J Mol Sci. 2023 Mar 24;24(7):6128. doi: 10.3390/ijms24076128.
5
ATM-Mediated Mitochondrial Radiation Responses of Human Fibroblasts.
Genes (Basel). 2021 Jun 30;12(7):1015. doi: 10.3390/genes12071015.
6
Metformin Use and Pancreatic Cancer Survival among Non-Hispanic White and African American U.S. Veterans with Diabetes Mellitus.
Cancer Epidemiol Biomarkers Prev. 2020 Jan;29(1):169-175. doi: 10.1158/1055-9965.EPI-19-0781. Epub 2019 Nov 4.
7
A role for ataxia telangiectasia mutated in insulin-independent stimulation of glucose transport.
Trends Cell Mol Biol. 2017;12:49-56.
8
Metformin as an Adjunctive Therapy for Pancreatic Cancer: A Review of the Literature on Its Potential Therapeutic Use.
Dig Dis Sci. 2018 Nov;63(11):2840-2852. doi: 10.1007/s10620-018-5233-y. Epub 2018 Aug 29.
9
A Genetic Interaction Map of Insulin Production Identifies Mfi as an Inhibitor of Mitochondrial Fission.
Endocrinology. 2018 Sep 1;159(9):3321-3330. doi: 10.1210/en.2018-00426.
10
Pharmacogenetics of Antidiabetic Drugs.
Adv Pharmacol. 2018;83:361-389. doi: 10.1016/bs.apha.2018.04.005. Epub 2018 May 14.
本文引用的文献
1
Interactions of tyrosine kinase inhibitors with organic cation transporters and multidrug and toxic compound extrusion proteins.
Mol Cancer Ther. 2011 Mar;10(3):531-9. doi: 10.1158/1535-7163.MCT-10-0731. Epub 2011 Jan 20.
2
Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metformin.
Pharmacogenet Genomics. 2010 Nov;20(11):687-99. doi: 10.1097/FPC.0b013e32833fe789.
3
Ionizing radiation activates AMP-activated kinase (AMPK): a target for radiosensitization of human cancer cells.
Int J Radiat Oncol Biol Phys. 2010 Sep 1;78(1):221-9. doi: 10.1016/j.ijrobp.2010.03.005. Epub 2010 Jul 7.
4
Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state.
J Clin Invest. 2010 Jul;120(7):2355-69. doi: 10.1172/JCI40671. Epub 2010 Jun 23.
5
Genotype-dependent effects of inhibitors of the organic cation transporter, OCT1: predictions of metformin interactions.
Pharmacogenomics J. 2011 Dec;11(6):400-11. doi: 10.1038/tpj.2010.54. Epub 2010 Jun 22.
6
Etoposide induces ATM-dependent mitochondrial biogenesis through AMPK activation.
PLoS One. 2008 Apr 23;3(4):e2009. doi: 10.1371/journal.pone.0002009.
7
AICAR induces phosphorylation of AMPK in an ATM-dependent, LKB1-independent manner.
Mol Cell Biochem. 2007 Dec;306(1-2):239-45. doi: 10.1007/s11010-007-9575-6. Epub 2007 Sep 5.
8
Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action.
J Clin Invest. 2007 May;117(5):1422-31. doi: 10.1172/JCI30558.
9
Role of AMP-activated protein kinase in mechanism of metformin action.
J Clin Invest. 2001 Oct;108(8):1167-74. doi: 10.1172/JCI13505.
10
Activation of the ATM kinase by ionizing radiation and phosphorylation of p53.
Science. 1998 Sep 11;281(5383):1677-9. doi: 10.1126/science.281.5383.1677.
Zotero 插件